NCT02481726View on ClinicalTrials.gov

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Conditions
Lung CancerLung Tuberculosis
Interventions
RADIATION

68Ga-labeled peptides of dimer RGD (Alfatide II) and 18F-FDG

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT02481726 - 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT | Biotech Hunter | Biotech Hunter